PHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Phreesia Inc (PHR) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. Despite some positive aspects like oversold RSI and constructive analyst ratings, the financial performance, insider selling, and lack of strong trading signals suggest a cautious approach. Holding the stock or waiting for further clarity is recommended.
The MACD histogram is positive at 0.0362, indicating mild bullish momentum, but it is contracting. RSI is at 18.377, signaling the stock is oversold. However, moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its support level of 11.231, with resistance at 12.675.
Analysts maintain constructive ratings with price targets significantly above the current price, citing long-term growth potential and undervaluation. The RSI indicates oversold conditions, suggesting a potential rebound.
Insiders are selling heavily, with a 495.07% increase in selling activity over the last month. Financial performance in Q3 2026 shows a significant drop in net income (-129.65% YoY) and EPS (-128.00% YoY), despite a 12.67% revenue increase. No recent news or congress trading data to support a positive sentiment.
In Q3 2026, revenue increased by 12.67% YoY to $120.33M, and gross margin improved slightly to 62.18%. However, net income dropped significantly by -129.65% YoY to $4.27M, and EPS fell by -128.00% YoY to 0.07, indicating profitability challenges.
Analysts maintain positive ratings with price targets ranging from $22 to $30, citing long-term growth potential and undervaluation. However, recent price target reductions reflect concerns about competitive risks and the need for the company to demonstrate consistent revenue and EBITDA growth to regain investor confidence.
